CorMedix Inc. (CRMD)
USD 9.38
(-2.8%)
USD 9.38
(-2.8%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -43.05 Million USD | -1.13% |
| 2022 | -42.57 Million USD | 19.11% |
| 2021 | -52.62 Million USD | -28.16% |
| 2020 | -41.06 Million USD | -148.53% |
| 2019 | -16.52 Million USD | -43.69% |
| 2018 | -11.49 Million USD | -10.78% |
| 2017 | -10.37 Million USD | -28.71% |
| 2016 | -8.06 Million USD | 31.76% |
| 2015 | -11.81 Million USD | -172.32% |
| 2014 | -4.33 Million USD | -82.8% |
| 2013 | -2.37 Million USD | -319.62% |
| 2012 | -565.72 Thousand USD | 71.5% |
| 2011 | -1.98 Million USD | 76.03% |
| 2010 | -8.28 Million USD | -167.57% |
| 2009 | 12.26 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -34.62 Million USD | 19.58% |
| 2024 Q3 | -34.72 Billion USD | -24.27% |
| 2024 Q2 | -27.94 Million USD | 19.29% |
| 2023 Q4 | -43.05 Million USD | 18.17% |
| 2023 FY | -43.05 Million USD | -1.13% |
| 2023 Q3 | -52.61 Million USD | -174.7% |
| 2023 Q2 | -19.15 Million USD | 22.54% |
| 2023 Q1 | -24.72 Million USD | 41.92% |
| 2022 Q1 | -44.49 Million USD | 15.45% |
| 2022 Q4 | -42.57 Million USD | -0.36% |
| 2022 FY | -42.57 Million USD | 19.11% |
| 2022 Q3 | -42.42 Million USD | 11.75% |
| 2022 Q2 | -48.06 Million USD | -8.03% |
| 2021 Q4 | -52.62 Million USD | 19.49% |
| 2021 Q3 | -65.36 Million USD | 9.36% |
| 2021 FY | -52.62 Million USD | -28.16% |
| 2021 Q2 | -72.11 Million USD | 4.11% |
| 2021 Q1 | -75.2 Million USD | -83.15% |
| 2020 Q4 | -41.06 Million USD | -23.26% |
| 2020 Q3 | -33.31 Million USD | -102.0% |
| 2020 FY | -41.06 Million USD | -148.53% |
| 2020 Q2 | -16.49 Million USD | -35.16% |
| 2020 Q1 | -12.2 Million USD | 26.15% |
| 2019 FY | -16.52 Million USD | -43.69% |
| 2019 Q4 | -16.52 Million USD | 17.97% |
| 2019 Q1 | -11.82 Million USD | -2.85% |
| 2019 Q2 | -7.99 Million USD | 32.39% |
| 2019 Q3 | -20.14 Million USD | -151.91% |
| 2018 Q2 | -4.7 Million USD | 42.39% |
| 2018 FY | -11.49 Million USD | -10.78% |
| 2018 Q4 | -11.49 Million USD | -78.44% |
| 2018 Q3 | -6.44 Million USD | -37.05% |
| 2018 Q1 | -8.16 Million USD | 21.37% |
| 2017 Q4 | -10.37 Million USD | -99.13% |
| 2017 FY | -10.37 Million USD | -28.71% |
| 2017 Q1 | -6.81 Million USD | 15.45% |
| 2017 Q2 | -7.93 Million USD | -16.41% |
| 2017 Q3 | -5.21 Million USD | 34.33% |
| 2016 Q1 | -13.18 Million USD | -11.57% |
| 2016 FY | -8.06 Million USD | 31.76% |
| 2016 Q4 | -8.06 Million USD | 17.93% |
| 2016 Q2 | -12.02 Million USD | 8.83% |
| 2016 Q3 | -9.82 Million USD | 18.25% |
| 2015 Q3 | -14.24 Million USD | 40.91% |
| 2015 Q1 | -8.79 Million USD | -102.77% |
| 2015 FY | -11.81 Million USD | -172.32% |
| 2015 Q4 | -11.81 Million USD | 17.05% |
| 2015 Q2 | -24.11 Million USD | -174.01% |
| 2014 FY | -4.33 Million USD | -82.8% |
| 2014 Q1 | -9.18 Million USD | -287.1% |
| 2014 Q2 | -7.65 Million USD | 16.73% |
| 2014 Q4 | -4.33 Million USD | 26.7% |
| 2014 Q3 | -5.92 Million USD | 22.63% |
| 2013 Q3 | 1.05 Million USD | 95.51% |
| 2013 Q4 | -2.37 Million USD | -325.69% |
| 2013 Q2 | 537.98 Thousand USD | 671.02% |
| 2013 FY | -2.37 Million USD | -319.62% |
| 2013 Q1 | -94.21 Thousand USD | 83.35% |
| 2012 Q2 | -893.93 Thousand USD | 51.81% |
| 2012 Q1 | -1.85 Million USD | 6.56% |
| 2012 Q3 | -824.15 Thousand USD | 7.81% |
| 2012 Q4 | -565.72 Thousand USD | 31.36% |
| 2012 FY | -565.72 Thousand USD | 71.5% |
| 2011 FY | -1.98 Million USD | 76.03% |
| 2011 Q3 | -2.88 Million USD | 39.01% |
| 2011 Q2 | -4.73 Million USD | 27.82% |
| 2011 Q1 | -6.56 Million USD | 20.76% |
| 2011 Q4 | -1.98 Million USD | 31.3% |
| 2010 Q2 | -10.58 Million USD | 9.71% |
| 2010 FY | -8.28 Million USD | -167.57% |
| 2010 Q3 | -9.52 Million USD | 10.05% |
| 2010 Q4 | -8.28 Million USD | 13.01% |
| 2010 Q1 | -11.72 Million USD | -195.63% |
| 2009 FY | 12.26 Million USD | 0.0% |
| 2009 Q4 | 12.26 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Absci Corporation | -72.59 Million USD | 40.697% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 126.193% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 102.302% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -57048.837% |
| Apollomics, Inc. | -27.39 Million USD | -57.155% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -6465.584% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 51.331% |
| Bicycle Therapeutics plc | -481.46 Million USD | 91.058% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 66.655% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 219.051% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 1135.912% |
| Chimerix, Inc. | -25.51 Million USD | -68.721% |
| CRISPR Therapeutics AG | -150.84 Million USD | 71.459% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 124.232% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 84.39% |
| Fortress Biotech, Inc. | 7.66 Million USD | 661.677% |
| Fortress Biotech, Inc. | 7.66 Million USD | 661.677% |
| Gritstone bio, Inc. | 39.49 Million USD | 209.021% |
| Allakos Inc. | -24.97 Million USD | -72.382% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -100.142% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -377.512% |
| Cytokinetics, Incorporated | 642.37 Million USD | 106.702% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 39.991% |
| Innoviva, Inc. | 255.56 Million USD | 116.846% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -366.078% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 5949.001% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -6.114% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -667.388% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 45.725% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -12.874% |
| ImmuCell Corporation | 10.99 Million USD | 491.723% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 72.07% |
| Incyte Corporation | -3.17 Billion USD | 98.644% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 370.798% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -3523.536% |
| Mustang Bio, Inc. | -3.73 Million USD | -1052.369% |
| MiMedx Group, Inc. | -33.9 Million USD | -26.995% |
| MEI Pharma, Inc. | -3.7 Million USD | -1062.011% |
| MacroGenics, Inc. | -66.98 Million USD | 35.728% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -492.514% |
| Mereo BioPharma Group plc | -51.46 Million USD | 16.353% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -184.9% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -321.505% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 219.574% |
| Minerva Neurosciences, Inc. | 41 Million USD | 204.995% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -93.651% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -1596.316% |
| NextCure, Inc. | -6.47 Million USD | -564.698% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -49.115% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 14.749% |
| Onconetix, Inc. | 5.33 Million USD | 907.522% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -574.91% |
| Opthea Limited | 28.15 Million USD | 252.899% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 327.068% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 724.438% |
| PDS Biotechnology Corporation | -32.7 Million USD | -31.623% |
| Precigen, Inc. | -481 Thousand USD | -8850.625% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -147.485% |
| Prime Medicine, Inc. | -27.94 Million USD | -54.084% |
| PureTech Health plc | -167.19 Million USD | 74.25% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -39.5% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -58.865% |
| Replimune Group, Inc. | 1.41 Million USD | 3149.044% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -259.019% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 254.904% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -1758.093% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 92.921% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -132.467% |
| Sesen Bio, Inc. | -112.55 Million USD | 61.749% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -506.373% |
| Solid Biosciences Inc. | -47.75 Million USD | 9.838% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 85.344% |
| SciSparc Ltd. | -2.06 Million USD | -1984.867% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 137.938% |
| TG Therapeutics, Inc. | 17.86 Million USD | 341.028% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -184.457% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -593.5% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 112.421% |
| UroGen Pharma Ltd. | 4.39 Million USD | 1080.472% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -79.109% |
| XOMA Corporation | -29 Million USD | -48.457% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 342.754% |
| AbCellera Biologics Inc. | -55.94 Million USD | 23.038% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -210.714% |
| Cassava Sciences, Inc. | -121.13 Million USD | 64.459% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 717.854% |
| Precision BioSciences, Inc. | -85.41 Million USD | 49.593% |
| Dyadic International, Inc. | -6.37 Million USD | -575.005% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -412.652% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -170.21% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -41.341% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -29.454% |
| IGM Biosciences, Inc. | -72.6 Million USD | 40.704% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -4.534% |
| Acelyrin, Inc. | -216.9 Million USD | 80.151% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -374.512% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -156.433% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -403.94% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 86.41% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 44.413% |
| Senti Biosciences, Inc. | 1.74 Million USD | 2574.282% |
| Mesoblast Limited | 55.96 Million USD | 176.93% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -70.222% |
| ChromaDex Corporation | -24.04 Million USD | -79.027% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -4893.975% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 170.282% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -478.808% |
| Seer, Inc. | -4.24 Million USD | -915.389% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 126.618% |
| Novavax, Inc. | -298.29 Million USD | 85.567% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -370.956% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 169.816% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -773.63% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 47.802% |
| Celcuity Inc. | 6.78 Million USD | 734.664% |
| ContextLogic Inc. | -232 Million USD | 81.443% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 82.236% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 61.051% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 100.938% |
| Amarin Corporation plc | -191.04 Million USD | 77.464% |
| AnaptysBio, Inc. | -18.15 Million USD | -137.191% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -274.142% |
| Aptorum Group Limited | 1.35 Million USD | 3272.516% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 34.725% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 1105.9% |
| Ardelyx, Inc. | 34.51 Million USD | 224.746% |
| Celularity Inc. | 65.19 Million USD | 166.042% |
| Omeros Corporation | 331.17 Million USD | 113.0% |
| Humacyte, Inc. | -22.48 Million USD | -91.464% |
| Immunocore Holdings plc | -358.59 Million USD | 87.994% |
| IO Biotech, Inc. | -140.69 Million USD | 69.401% |
| GT Biopharma, Inc. | -1.02 Million USD | -4116.7% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 77.126% |
| Summit Therapeutics Inc. | 34.67 Million USD | 224.164% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -610.203% |
| Pulmatrix, Inc. | -10.41 Million USD | -313.291% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 61.354% |
| Evogene Ltd. | -19.63 Million USD | -119.275% |
| BioLineRx Ltd. | 7.33 Million USD | 686.866% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 63.217% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 42.653% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 75.945% |
| scPharmaceuticals Inc. | -6.54 Million USD | -557.792% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -192.04% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 68.203% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 5949.001% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -132.467% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 79.318% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 53.589% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -93.165% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 76.679% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -61.493% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 453.955% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -157.92% |
| Daré Bioscience, Inc. | -5.15 Million USD | -734.689% |
| bluebird bio, Inc. | 108.57 Million USD | 139.654% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 111.367% |
| DBV Technologies S.A. | -126.98 Million USD | 66.097% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 75.431% |
| Galecto, Inc. | -21.21 Million USD | -102.925% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -532.846% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 53.066% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 36.485% |
| GlycoMimetics, Inc. | -40.98 Million USD | -5.046% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 136.925% |
| ADMA Biologics, Inc. | 90.06 Million USD | 147.801% |
| Clene Inc. | 3.34 Million USD | 1388.997% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 87.489% |
| Aptose Biosciences Inc. | -8.19 Million USD | -425.36% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -1275.911% |
| Soligenix, Inc. | -4.95 Million USD | -769.467% |
| Century Therapeutics, Inc. | 847 Thousand USD | 5182.94% |
| Kura Oncology, Inc. | -20.11 Million USD | -114.0% |
| Surrozen, Inc. | -32.66 Million USD | -31.804% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -5.196% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 2463.321% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -1246.653% |
| Autolus Therapeutics plc | -186.59 Million USD | 76.928% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 12.679% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 225.635% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -81.833% |
| GRI Bio, Inc. | -1.79 Million USD | -2299.805% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -379.264% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 906.68% |
| INmune Bio, Inc. | -25.41 Million USD | -69.425% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 128.521% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 15.015% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -164.949% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -363.367% |
| Jaguar Health, Inc. | 29.39 Million USD | 246.482% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -1392.326% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 213.251% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 405.749% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 235.024% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 111.391% |
| Verastem, Inc. | -37.27 Million USD | -15.49% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 16.986% |
| Histogen Inc. | -7.48 Million USD | -475.03% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -99.254% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 67.248% |
| Surrozen, Inc. | -32.66 Million USD | -31.804% |
| Organovo Holdings, Inc. | -1.5 Million USD | -2756.835% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -924.209% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -413.683% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 0.897% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -195.348% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -5862.455% |
| Kronos Bio, Inc. | -36.05 Million USD | -19.411% |
| Turnstone Biologics Corp. | -14.58 Million USD | -195.204% |
| Synaptogenix, Inc. | -28.66 Million USD | -50.21% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -4499.627% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 6955.494% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 188.345% |
| Exelixis, Inc. | -73.05 Million USD | 41.064% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -79.288% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 82.163% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 48.809% |
| ESSA Pharma Inc. | -33.62 Million USD | -28.05% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -1535.646% |
| Avid Bioservices, Inc. | 169.72 Million USD | 125.366% |
| Insmed Incorporated | 721.62 Million USD | 105.966% |
| MediWound Ltd. | -5.32 Million USD | -708.953% |
| OmniAb, Inc. | 9.2 Million USD | 567.809% |
| Alector, Inc. | -35.63 Million USD | -20.808% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 150.078% |
| Zai Lab Limited | -775 Million USD | 94.445% |
| AlloVir, Inc. | -62.69 Million USD | 31.327% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 112.642% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -226.873% |
| Aura Biosciences, Inc. | -21.52 Million USD | -100.012% |
| Immunic, Inc. | -45.34 Million USD | 5.045% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 77.718% |
| Veracyte, Inc. | -203.82 Million USD | 78.878% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 106.745% |
| FibroGen, Inc. | 56.76 Million USD | 175.841% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 583.464% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 67.89% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -1422.86% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -1979.482% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -1188.611% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 74.059% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 102.743% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -75.926% |
| XBiotech Inc. | -200.02 Million USD | 78.476% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 48.809% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 86.406% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -2397.245% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 1050.806% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -22.09% |
| Agenus Inc. | 274.13 Million USD | 115.705% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 44.246% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 856.502% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 74.737% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 53.393% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 105.847% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -299.836% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 22.587% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -1146.933% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -379.637% |
| Lantern Pharma Inc. | -21.7 Million USD | -98.369% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -918.03% |
| Ainos, Inc. | 4.07 Million USD | 1155.745% |
| Pluri Inc. | 22.82 Million USD | 288.587% |
| Prothena Corporation plc | -608.34 Million USD | 92.923% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 63.747% |
| Rallybio Corporation | -24.1 Million USD | -78.626% |
| Kodiak Sciences Inc. | -103.87 Million USD | 58.554% |
| Cue Biopharma, Inc. | -33.81 Million USD | -27.303% |
| MeiraGTx Holdings plc | -40.3 Million USD | -6.825% |
| Annexon, Inc. | -193.75 Million USD | 77.78% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -146.028% |
| Moderna, Inc. | -2.9 Billion USD | 98.519% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -75.188% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -39.324% |
| Blueprint Medicines Corporation | 702.83 Million USD | 106.126% |
| Immix Biopharma, Inc. | -17.5 Million USD | -145.877% |
| CalciMedica, Inc. | -5.53 Million USD | -678.526% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 47.537% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -7.532% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 74.409% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -29.47% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -620.303% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 28.179% |
| Nutriband Inc. | -251.65 Thousand USD | -17007.613% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -26.183% |
| Vor Biopharma Inc. | 4.3 Million USD | 1101.221% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 99.287% |
| Alkermes plc | -166.73 Million USD | 74.18% |
| ProKidney Corp. | -56.23 Million USD | 23.443% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 11.546% |
| Arcellx, Inc. | -296.95 Million USD | 85.502% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 103.157% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -56.754% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 193.294% |
| Atai Life Sciences N.V. | -28.55 Million USD | -50.755% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 2030.148% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -88.694% |
| MediciNova, Inc. | -50.78 Million USD | 15.223% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 45.368% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -191286.997% |
| GeoVax Labs, Inc. | -6.45 Million USD | -567.213% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 78.454% |
| Biomea Fusion, Inc. | -166.57 Million USD | 74.154% |
| RenovoRx, Inc. | -1.17 Million USD | -3570.29% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 54.607% |
| Geron Corporation | 14.76 Million USD | 391.664% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1042.893% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 81.636% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 54.302% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 55.011% |
| Royalty Pharma plc | 5.65 Billion USD | 100.761% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -10.185% |
| Imunon, Inc. | -4.21 Million USD | -921.69% |
| BioAtla, Inc. | -109.01 Million USD | 60.506% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 459.79% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -103.049% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 69.408% |
| Structure Therapeutics Inc. | -124.33 Million USD | 65.375% |
| 89bio, Inc. | -289.05 Million USD | 85.106% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -159.979% |
| aTyr Pharma, Inc. | -7.44 Million USD | -477.964% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 65.457% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 47.355% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -4910.86% |
| Akari Therapeutics, Plc | -3.84 Million USD | -1019.701% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 2752.83% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 103.118% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 151.499% |
| Liquidia Corporation | -80.17 Million USD | 46.303% |
| Entera Bio Ltd. | -10.62 Million USD | -305.048% |
| GH Research PLC | -78.07 Million USD | 44.859% |
| Vericel Corporation | 1.27 Million USD | 3471.379% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -145.118% |
| Xencor, Inc. | 29.64 Million USD | 245.232% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -2085.615% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -164.949% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -17479.052% |
| Vaxcyte, Inc. | -368.22 Million USD | 88.308% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 68.744% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 65.944% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -3523.536% |
| Portage Biotech Inc. | -4.98 Million USD | -764.335% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -191286.997% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 34.889% |
| OncoCyte Corporation | -6.56 Million USD | -555.988% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 4897.402% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -845.037% |
| Purple Biotech Ltd. | -14.13 Million USD | -204.516% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -131.851% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -634.684% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 26.808% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -81.228% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -87.38% |
| United Therapeutics Corporation | -507.7 Million USD | 91.52% |
| HilleVax, Inc. | -165.48 Million USD | 73.984% |
| Silo Pharma, Inc. | -3.52 Million USD | -1121.587% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 43252.187% |
| Pharming Group N.V. | 109.8 Million USD | 139.209% |
| Tharimmune, Inc. | -10.93 Million USD | -293.7% |
| Genprex, Inc. | -6.73 Million USD | -538.986% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 62.976% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 88.327% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 522.29% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -2972.984% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -1197.956% |
| OKYO Pharma Limited | -826.84 Thousand USD | -5106.822% |
| Savara Inc. | 153 Thousand USD | 28238.892% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 444.117% |
| Curis, Inc. | -23.88 Million USD | -80.234% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -5447.917% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 3733.123% |
| BeiGene, Ltd. | -2.25 Billion USD | 98.089% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 76.802% |
| Erasca, Inc. | -37.21 Million USD | -15.683% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -3242.863% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -3242.863% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -315.886% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -296.14% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -37.237% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -33.405% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -25.24% |
| Adicet Bio, Inc. | -138.78 Million USD | 68.979% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 121.737% |
| Aditxt, Inc. | 18.12 Million USD | 337.585% |
| Adagene Inc. | -87.62 Million USD | 50.869% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -933.567% |
| Quantum-Si incorporated | -118.55 Million USD | 63.686% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -476.016% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 11.248% |
| Compugen Ltd. | -12.9 Million USD | -233.637% |
| Generation Bio Co. | 31.44 Million USD | 236.901% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 75.45% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -39.225% |
| Invivyd, Inc. | -198.47 Million USD | 78.308% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 52.307% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -1695.584% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 39.183% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -530.806% |
| 2seventy bio, Inc. | 181.71 Million USD | 123.692% |
| Instil Bio, Inc. | 75.35 Million USD | 157.131% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -374.005% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -1281.499% |
| GeoVax Labs, Inc. | -6.45 Million USD | -567.213% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -65.589% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -952.225% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -726.502% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 66.96% |
| Evaxion Biotech A/S | 5.28 Million USD | 914.333% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 61.754% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 67.204% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 16.419% |
| Cingulate Inc. | 3.08 Million USD | 1496.592% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -1365.867% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 699.033% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 59.208% |
| Clearmind Medicine Inc. | -3.94 Million USD | -991.972% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 557.567% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 3052.59% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 20.649% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 349.175% |
| ImmunityBio, Inc. | 618.22 Million USD | 106.964% |
| Korro Bio, Inc. | -132.94 Million USD | 67.616% |
| Kineta, Inc. | -4.54 Million USD | -848.084% |
| BioVie Inc. | -17.73 Million USD | -142.791% |
| Codexis, Inc. | -43.27 Million USD | 0.505% |
| Celularity Inc. | 65.19 Million USD | 166.042% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 158.085% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -1258.552% |
| Virax Biolabs Group Limited | -3.36 Million USD | -1179.442% |
| Cibus, Inc. | -8.07 Million USD | -432.96% |
| IN8bio, Inc. | -16.38 Million USD | -162.691% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 119690.292% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -1125.52% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 104.084% |
| Eyenovia, Inc. | 1.25 Million USD | 3520.389% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 260.017% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -1227.552% |
| Elevation Oncology, Inc. | -19.11 Million USD | -125.194% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -29.493% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -120.714% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 26.875% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -107.712% |
| Moolec Science SA | 117.61 Thousand USD | 36704.293% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -12.119% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -13.541% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 69.557% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -91.387% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -515.966% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -702.79% |
| Humacyte, Inc. | -22.48 Million USD | -91.464% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -70.559% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -2314.61% |
| Genelux Corporation | -6.89 Million USD | -524.04% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -38.615% |
| Notable Labs, Ltd. | -9.77 Million USD | -340.39% |
| Immunovant, Inc. | -635.22 Million USD | 93.223% |
| Quantum-Si incorporated | -118.55 Million USD | 63.686% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -939.163% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 636.346% |
| Acasti Pharma Inc. | -23 Million USD | -87.144% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -1178.574% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 74.567% |
| PepGen Inc. | -60.67 Million USD | 29.038% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -125.099% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -4893.975% |
| Immuneering Corporation | -54.94 Million USD | 21.641% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -924.209% |
| Belite Bio, Inc | -87.27 Million USD | 50.668% |
| XOMA Corporation | -29 Million USD | -48.457% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 39.103% |
| Bionomics Limited | 227 Million USD | 118.965% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -1599.665% |
| uniQure N.V. | -102.95 Million USD | 58.182% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -933.567% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 205.132% |
| Forte Biosciences, Inc. | -11.96 Million USD | -259.941% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -1291.394% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 40715.571% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -1227.552% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 583.464% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -480.535% |
| Altimmune, Inc. | -134.48 Million USD | 67.988% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 76.791% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -1599.665% |
| Peak Bio, Inc. | 10.34 Million USD | 516.362% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -15112.899% |
| Benitec Biopharma Inc. | -50.58 Million USD | 14.886% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 58.737% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 319.152% |
| Zura Bio Limited | -99.8 Million USD | 56.864% |
| PolyPid Ltd. | 6.17 Million USD | 797.772% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 319.152% |
| argenx SE | -2.02 Billion USD | 97.878% |
| Immunome, Inc. | -97.02 Million USD | 55.629% |
| Verona Pharma plc | -220.44 Million USD | 80.47% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 39.991% |
| Shattuck Labs, Inc. | -121.42 Million USD | 64.544% |
| CervoMed Inc. | -7.79 Million USD | -452.462% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -884.507% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 67.32% |
| Moolec Science SA | 117.61 Thousand USD | 36704.293% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -1781.684% |
| Design Therapeutics, Inc. | -18.15 Million USD | -137.204% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 38.829% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 483.302% |
| Achilles Therapeutics plc | -126.92 Million USD | 66.08% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 3052.59% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -478.663% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 112.655% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 281.388% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 90.379% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 69.316% |
| Beam Therapeutics Inc. | -262.72 Million USD | 83.613% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 297.344% |
| AEON Biopharma, Inc. | -4.88 Million USD | -782.223% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 22.933% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 56.887% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -1733.744% |
| NeurAxis, Inc. | 145.7 Thousand USD | 29648.734% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -10.317% |
| Lumos Pharma, Inc. | -28.49 Million USD | -51.099% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -107.244% |
| Palisade Bio, Inc. | -12.06 Million USD | -256.897% |
| Nutriband Inc. | -251.65 Thousand USD | -17007.613% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 48.305% |
| Neurogene Inc. | -131.95 Million USD | 67.373% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -777.012% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 88.586% |
| Athira Pharma, Inc. | -88.99 Million USD | 51.626% |
| HCW Biologics Inc. | 2.85 Million USD | 1607.084% |
| XOMA Corporation | -29 Million USD | -48.457% |
| Nektar Therapeutics | 210.24 Million USD | 120.478% |
| Arvinas, Inc. | -313.8 Million USD | 86.28% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 2752.83% |
| Merus N.V. | -192.88 Million USD | 77.68% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 171.772% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -520.532% |
| Rezolute, Inc. | -68.16 Million USD | 36.844% |
| Clene Inc. | 3.34 Million USD | 1388.997% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -226.477% |
| BeyondSpring Inc. | -13.75 Million USD | -212.995% |
| Synlogic, Inc. | -6.68 Million USD | -544.017% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 3896.517% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -409.196% |
| Peak Bio, Inc. | 10.34 Million USD | 516.362% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 47.764% |
| Krystal Biotech, Inc. | -350.23 Million USD | 87.708% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 134.685% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 74.525% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -1263.654% |
| MannKind Corporation | 143.89 Million USD | 129.919% |
| Ikena Oncology, Inc. | -109.15 Million USD | 60.559% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -468.65% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -30.068% |
| Gossamer Bio, Inc. | 180.35 Million USD | 123.871% |
| CohBar, Inc. | -5.93 Million USD | -625.922% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -44.724% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1042.893% |
| Legend Biotech Corporation | -949.39 Million USD | 95.465% |
| Mural Oncology plc | -255.84 Million USD | 83.172% |
| Disc Medicine, Inc. | -358.28 Million USD | 87.984% |
| Champions Oncology, Inc. | 4.81 Million USD | 994.69% |
| REGENXBIO Inc. | 54.76 Million USD | 178.609% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -15910.184% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 71.493% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -377.724% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 46.64% |
| Vaxart, Inc. | -8.24 Million USD | -422.418% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 14.204% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 66.145% |
| Cellectis S.A. | -43.85 Million USD | 1.83% |
| Longeveron Inc. | -2.9 Million USD | -1380.485% |
| Repare Therapeutics Inc. | -107.85 Million USD | 60.084% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 104.446% |
| Inozyme Pharma, Inc. | 12 Million USD | 458.651% |
| Revolution Medicines, Inc. | -608.2 Million USD | 92.921% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -3400.204% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 83.761% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 71.312% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -175.149% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -5717.906% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 99.55% |
| Denali Therapeutics Inc. | -74.86 Million USD | 42.493% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -259.019% |
| Veru Inc. | 4.77 Million USD | 1000.686% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -282.825% |
| Cingulate Inc. | 3.08 Million USD | 1496.592% |
| Passage Bio, Inc. | 4.58 Million USD | 1038.986% |
| Context Therapeutics Inc. | -14.44 Million USD | -197.945% |
| Exicure, Inc. | 5.84 Million USD | 836.066% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 81.312% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -8.801% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 374.377% |
| Nuvalent, Inc. | -335.38 Million USD | 87.163% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 2582.355% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 42.197% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -384.28% |
| OmniAb, Inc. | 9.2 Million USD | 567.809% |
| Anew Medical, Inc. | 1.43 Million USD | 3105.484% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 362.808% |
| Lipocine Inc. | -4.75 Million USD | -805.493% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 60.8% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 382.664% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 15.015% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 272.957% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -540.567% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 34.597% |
| Ocugen, Inc. | -32.52 Million USD | -32.384% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 49.69% |
| Q32 Bio Inc. | -37.94 Million USD | -13.451% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -6755.494% |
| Alumis Inc. Common Stock | -13.52 Million USD | -218.224% |
| Equillium, Inc. | -22.39 Million USD | -92.267% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -68.384% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -31.955% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -17265.833% |
| Dominari Holdings Inc. | 195 Thousand USD | 22178.208% |
| Edesa Biotech, Inc. | -5.26 Million USD | -717.415% |
| vTv Therapeutics Inc. | -8.91 Million USD | -382.814% |
| Bio-Techne Corporation | 267.74 Million USD | 116.08% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -165.609% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 63.544% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -412.347% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -240.309% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 82.436% |
| Nkarta, Inc. | 57.29 Million USD | 175.137% |
| BioCardia, Inc. | 212 Thousand USD | 20407.785% |
| Iterum Therapeutics plc | 13.43 Million USD | 420.379% |